Abstract
Clinical practice guidelines recommend yearly surveillance mammography for breast cancer survivors, yet many women do not receive this service. The objective of this study was to evaluate factors related to long-term surveillance mammography adherence among breast cancer survivors. We conducted a retrospective cohort study among women ≥18 years, diagnosed with incident stage I or II breast cancer between 1990 and 2008. We used medical record and administrative health plan data to ascertain covariates and receipt of surveillance mammography for up to 10 years after completing breast cancer treatment. Surveillance included post-diagnosis screening exams among asymptomatic women. We used multivariable repeated measures generalized estimating equation regression models to estimate odds ratios and robust 95 % confidence intervals to examine factors related to the annual receipt of surveillance mammography. The analysis included 3,965 women followed for a median of six surveillance years; 79 % received surveillance mammograms in year 1 but decreased to 63 % in year 10. In multivariable analyses, women, who were <40 years or 80+ years of age (compared to 50–59 years), current smokers, had greater comorbidity, were diagnosed more recently, had stage II cancer, or were treated with mastectomy or breast conserving surgery without radiation, were less likely than other women to receive surveillance mammography. Women with outpatient visits during the year to primary care providers, oncologists, or both were more likely to undergo surveillance. In this large cohort study of women diagnosed with early-stage invasive breast cancer, we found that important subgroups of women are at high risk for non-adherence to surveillance recommendations, even among younger breast cancer survivors. Efforts should be undertaken to actively engage breast cancer survivors in managing long-term surveillance care.


Similar content being viewed by others
References
Howlader N, Noone AM, Krapcho M, et al (2011) SEER Cancer Statistics Review, 1975–2008, National Cancer Institute. http://seer.cancer.gov/csr/1975_2008/. Accessed 11 June 2011
Lash TL, Fox MP, Buist DS et al (2007) Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol 25:3001–3006. doi:10.1200/JCO.2006.09.9572
Carlson RW, Allred DC, Anderson BO et al (2011) Invasive breast cancer. J Natl Compr Canc Netw 9:136–222
Khatcheressian JL, Hurley P, Bantug E et al (2013) Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:961–965. doi:10.1200/JCO.2012.45.9859
Field TS, Doubeni C, Fox MP et al (2008) Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med 23:158–163. doi:10.1007/s11606-007-0471-2
Andersen MR, Urban N (1998) The use of mammography by survivors of breast cancer. Am J Public Health 88:1713–1715
Geller BM, Kerlikowske K, Carney PA et al (2003) Mammography surveillance following breast cancer. Breast Cancer Res Treat 81:107–115. doi:10.1023/A:1025794629878
Lash TL, Silliman RA (2001) Medical surveillance after breast cancer diagnosis. Med Care 39:945–955
Schapira MM, McAuliffe TL, Nattinger AB (2000) Underutilization of mammography in older breast cancer survivors. Med Care 38:281–289
Keating NL, Landrum MB, Guadagnoli E et al (2006) Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol 24:85–94. doi:10.1200/JCO.2005.02.4174
Doubeni CA, Field TS, Ulcickas Yood M et al (2006) Patterns and predictors of mammography utilization among breast cancer survivors. Cancer 106:2482–2488. doi:10.1002/cncr.21893
Demicheli R, Biganzoli E, Boracchi P et al (2008) Recurrence dynamics does not depend on the recurrence site. Breast Cancer Res 10:R83. doi:10.1186/bcr2152
Retsky M, Demicheli R, Hrushesky WJ (2005) Does surgery induce angiogenesis in breast cancer? Indirect evidence from relapse pattern and mammography paradox. Int J Surg 3:179–187. doi:10.1016/j.ijsu.2005.08.002
Wirtz HS, Buist DS, Gralow JR et al (2013) Frequent antibiotic use and second breast cancer events. Cancer Epidemiol Biomarkers Prev 22(9):1588–1599. doi:10.1158/1055-9965.EPI-13-0454
Greene FL, Page DL, Fleming ID et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York
Chubak J, Buist DS, Boudreau DM et al (2008) Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat 112:123–132. doi:10.1007/s10549-007-9828-9
Geiger AM, Thwin SS, Lash TL et al (2007) Recurrences and second primary breast cancers in older women with initial early-stage disease. Cancer 109:966–974. doi:10.1002/cncr.22472
Calip GS, Boudreau DM, Loggers ET (2013) Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment. Breast Cancer Res Treat 138:225–233. doi:10.1007/s10549-013-2424-2
Taplin SH, Thompson RS, Schnitzer F et al (1990) Revisions in the risk-based Breast Cancer Screening Program at Group Health Cooperative. Cancer 66:812–818
Group Health Research Institute (2012) Group Health Breast Cancer Surveillance Registry. http://www.grouphealthresearch.org/surveillanceproject/. Accessed 9 July 2013
Saunders KW, Davis RL, Stergachis A (2005) Group Health Cooperative. In: Strom BL (ed) Pharmacoepidemiology, 4th edn. Wiley, West Sussex, pp 223–239
Houssami N, Abraham LA, Miglioretti DL et al (2011) Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA 305:790–799. doi:10.1001/jama.2011.188
Phipps AI, Ichikawa L, Bowles EJ et al (2010) Defining menopausal status in epidemiologic studies: a comparison of multiple approaches and their effects on breast cancer rates. Maturitas 67:60–66. doi:10.1016/j.maturitas.2010.04.015
Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619
Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121–130
Hudis CA, Barlow WE, Costantino JP et al (2007) Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol 25:2127–2132. doi:10.1200/JCO.2006.10.3523
Onega T, Weiss J, Diflorio R et al (2012) Evaluating surveillance breast imaging and biopsy in older breast cancer survivors. Int J Breast Cancer 2012:347646. doi:10.1155/2012/347646
Buist DS, Abraham LA, Barlow WE et al (2010) Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat 124:863–873. doi:10.1007/s10549-010-1106-6
Jackson LA, Nelson JC, Benson P et al (2006) Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 35:345–352. doi:10.1093/ije/dyi275
Acknowledgments
This manuscript was supported by grant numbers CA120562 (Boudreau), CRTG-03-024-01 (Buist), and CA093772 (Silliman). Part of the data collection was supported by a grant from the National Cancer Institute: U01CA63731, PI: Buist).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wirtz, H.S., Boudreau, D.M., Gralow, J.R. et al. Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors. Breast Cancer Res Treat 143, 541–550 (2014). https://doi.org/10.1007/s10549-013-2816-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-013-2816-3